Patent details
EP3679141 Title: METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA
Basic Information
- Publication number:
- EP3679141
- PCT Application Number:
- US2018055735
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188670970
- PCT Publication Number:
- WO2019075419
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA
- French Title of Invention:
- MÉTHODES ET COMPOSITIONS POUR INHIBER L'EXPRESSION DE LA LDHA
- German Title of Invention:
- VERFAHREN UND ZUSAMMENSETZUNGEN ZUR HEMMUNG DER LDHA-EXPRESSION
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 29/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 10/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 12/10/2018
- Grant date:
- 07/06/2023
- EP Publication Date:
- 15/07/2020
- PCT Publication Date:
- 18/04/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/10/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Novo Nordisk Health Care AG
- Address:
- The Circle 32/38 8058 Zürich, Switzerland (CH)
Inventor
1
- Name:
- SAXENA, Utsav
- Address:
- United States (US)
2
- Name:
- STORR, Rachel
- Address:
- United States (US)
3
- Name:
- DUDEK, Henryk, T.
- Address:
- United States (US)
4
- Name:
- WANG, Weimin
- Address:
- United States (US)
5
- Name:
- NAZEF, Naim
- Address:
- United States (US)
6
- Name:
- PURSELL, Natalie
- Address:
- United States (US)
7
- Name:
- BROWN, Bob, D.
- Address:
- United States (US)
8
- Name:
- LAI, Cheng
- Address:
- United States (US)
9
- Name:
- KIM, Boyoung
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762572403 P
- Priority Date:
- 13/10/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762572398 P
- Priority Date:
- 13/10/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201862726950 P
- Priority Date:
- 04/09/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 15/113; A61K 31/713;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202324
- Publication date:
- 14/06/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|